Metabolic syndrome increases a person's risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study, published in Cell Metabolism, ...
Apr 11, 2022
0
138
Investigators at the University of Miami Miller School of Medicine have designed RNA molecules that home to human pancreatic beta cells, the cells that produce insulin and are destroyed in patients with type 1 and type 2 ...
Apr 7, 2022
0
46
A study published in the Clinical Gastroenterology and Hepatology journal, and led by UNC School of Medicine researchers, found that alcohol-associated liver disease (ALD) mortality accelerated during the COVID-19 Pandemic.
Apr 6, 2022
0
17
Scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported that inhibiting a liver enzyme in obese mice decreased the rodents' appetite, increased energy expenditure ...
Apr 5, 2022
0
89
Increased levels of blood fats in people with type 2 diabetes and obesity are more harmful than previously thought, a new study has found.
Apr 1, 2022
0
82
New research from Mayo Clinic shows that lack of sufficient sleep combined with free access to food increases calorie consumption and consequently fat accumulation, especially unhealthy fat inside the belly.
Mar 28, 2022
0
66
When a baby or toddler dies without warning, parents often blame themselves. A study at Boston Children's may provide some insight into sudden, unexplained child deaths and perhaps a measure of closure. It suggests that at ...
Mar 22, 2022
0
12
For patients with moderate- to end-stage chronic kidney disease, elobixibat is associated with improvement in constipation and lipid metabolism, according to a study recently published in Frontiers in Medicine.
Mar 21, 2022
0
12
Cells use their molecular architecture to regulate their metabolic functions, and repairing diseased cells' architecture to a healthier state can also repair metabolism, according to a study led by Harvard T.H. Chan School ...
Mar 15, 2022
0
126
An interdisciplinary research team at The University of Texas at San Antonio has successfully developed an innovative inhibitor that shows promise in fighting obesity and potentially preventing heart disease. Francis Yoshimoto, ...
Mar 4, 2022
0
918
